Cronos Group

Cronos Group

We are a geographically diversified and vertically integrated cannabis group that operates within Health Canada’s Access to Cannabis for Medical Purposes Regulations and distributes globally.
Growers / Distributors
Company Details
Drug Manufacturers - Specialty & Generic
Full time employees

Cronos Group News

13 hours ago

2 Big Earnings Reports I'll Be Watching This Week

has put together some big revenue growth through the past few years. Since the company has so much investment capital from the Altria deal, focus will be on sales potential and how they'll work with Altria,...

16 hours ago

5 Ways Technology Can Transform the Marijuana Industry

The traditional cannabis industry is evolving before our eyes.

22 Mar

Cramer's game plan: 'Get ready to ride through these troubled waters'

No summary available.

22 Mar

7 Marijuana Stocks to Play the CBD Trend

Cannabidiol (CBD) is emerging as a red-hot category of the marijuana industry. CBD includes compounds in the cannabis sativa plant that do not produce a high. In fact, over the years, CBDs have been shown...

22 Mar

Wall Street Expects These Pot Stocks to Drop by 22% to 44%

These red-hot marijuana stocks may now be too hot to handle.

21 Mar

Legal Marijuana Could Hurt Alcohol Stocks

The ongoing wave of cannabis legalization is good for pot companies, but the trend could be a downer for alcohol stocks, warns DataTrek.

21 Mar

There’s Smoke, But Is There Still Fire for ACB Stock?

Cannabis stocks are climbing this year and Aurora Cannabis (NYSE:ACB) is among the leaders of that pack. Shares of ACB stock have nearly doubled year-to-date and are in the midst of a breathtaking March...

21 Mar

Will Cronos Group Earnings Get an Altria Bump?

With the cigarette giant's investment in the cannabis company complete, it's up to Cronos to perform.

20 Mar

These Marijuana Stocks Have Doubled So Far in 2019

Find out if further gains are around the corner.

20 Mar

Options Traders Expect Huge Moves in Cronos (CRON) Stock

Investors need to pay close attention to Cronos (CRON) stock based on the movements in the options market lately.

Load more

About Cronos Group

Our goal is to establish the most valuable international cannabis community comprised of passionate, daring people, driven by quality and integrity, who are determined to write history, not read about it.
We don’t strive to follow best practices; we aspire to set them by building industry leading companies that transform the perception of cannabis and responsibly elevate the consumer experience.
We never lose sight of our consumer’s trust as a measure of our success, building an iconic portfolio that offers the most enjoyable products on the market while generating value for our shareholders.

Features Cronos Group

Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations MMPR.

The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control. Cronos Group Inc. was incorporated in January, 2013 and is based in Toronto, Canada with an additional office in Toronto, Canada.

$ 19.23
Share volume:
6.324 M
Total value:
135.177 M
Market cap:
6.318 B